IBDEI0F9 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7375,1,4,0)
 ;;=4^695.12
 ;;^UTILITY(U,$J,358.3,7375,1,5,0)
 ;;=5^Erythema Multiforme,Major
 ;;^UTILITY(U,$J,358.3,7375,2)
 ;;=^336635
 ;;^UTILITY(U,$J,358.3,7376,0)
 ;;=695.13^^55^579^67
 ;;^UTILITY(U,$J,358.3,7376,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7376,1,4,0)
 ;;=4^695.13
 ;;^UTILITY(U,$J,358.3,7376,1,5,0)
 ;;=5^Stevens-Johnson Syndrome
 ;;^UTILITY(U,$J,358.3,7376,2)
 ;;=^336636
 ;;^UTILITY(U,$J,358.3,7377,0)
 ;;=695.14^^55^579^59
 ;;^UTILITY(U,$J,358.3,7377,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7377,1,4,0)
 ;;=4^695.14
 ;;^UTILITY(U,$J,358.3,7377,1,5,0)
 ;;=5^SJS-TEN Syndrome
 ;;^UTILITY(U,$J,358.3,7377,2)
 ;;=^336637
 ;;^UTILITY(U,$J,358.3,7378,0)
 ;;=695.15^^55^579^71
 ;;^UTILITY(U,$J,358.3,7378,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7378,1,4,0)
 ;;=4^695.15
 ;;^UTILITY(U,$J,358.3,7378,1,5,0)
 ;;=5^Toxic Epidermal Necrolysis
 ;;^UTILITY(U,$J,358.3,7378,2)
 ;;=^336638
 ;;^UTILITY(U,$J,358.3,7379,0)
 ;;=695.19^^55^579^30
 ;;^UTILITY(U,$J,358.3,7379,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7379,1,4,0)
 ;;=4^695.19
 ;;^UTILITY(U,$J,358.3,7379,1,5,0)
 ;;=5^Erythema Multiforme NEC
 ;;^UTILITY(U,$J,358.3,7379,2)
 ;;=^336639
 ;;^UTILITY(U,$J,358.3,7380,0)
 ;;=V18.0^^55^580^15
 ;;^UTILITY(U,$J,358.3,7380,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7380,1,4,0)
 ;;=4^V18.0
 ;;^UTILITY(U,$J,358.3,7380,1,5,0)
 ;;=5^Family h/o Diabetes Mellitus
 ;;^UTILITY(U,$J,358.3,7380,2)
 ;;=^295311
 ;;^UTILITY(U,$J,358.3,7381,0)
 ;;=V16.0^^55^580^7
 ;;^UTILITY(U,$J,358.3,7381,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7381,1,4,0)
 ;;=4^V16.0
 ;;^UTILITY(U,$J,358.3,7381,1,5,0)
 ;;=5^Family h/o Cancer of GI Tract
 ;;^UTILITY(U,$J,358.3,7381,2)
 ;;=^295292
 ;;^UTILITY(U,$J,358.3,7382,0)
 ;;=V16.1^^55^580^8
 ;;^UTILITY(U,$J,358.3,7382,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7382,1,4,0)
 ;;=4^V16.1
 ;;^UTILITY(U,$J,358.3,7382,1,5,0)
 ;;=5^Family h/o Cancer of Lung
 ;;^UTILITY(U,$J,358.3,7382,2)
 ;;=^295293
 ;;^UTILITY(U,$J,358.3,7383,0)
 ;;=V19.6^^55^580^1
 ;;^UTILITY(U,$J,358.3,7383,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7383,1,4,0)
 ;;=4^V19.6
 ;;^UTILITY(U,$J,358.3,7383,1,5,0)
 ;;=5^Family h/o Allergic Disorder
 ;;^UTILITY(U,$J,358.3,7383,2)
 ;;=^295326
 ;;^UTILITY(U,$J,358.3,7384,0)
 ;;=V18.2^^55^580^2
 ;;^UTILITY(U,$J,358.3,7384,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7384,1,4,0)
 ;;=4^V18.2
 ;;^UTILITY(U,$J,358.3,7384,1,5,0)
 ;;=5^Family h/o Anemia
 ;;^UTILITY(U,$J,358.3,7384,2)
 ;;=^295313
 ;;^UTILITY(U,$J,358.3,7385,0)
 ;;=V17.5^^55^580^4
 ;;^UTILITY(U,$J,358.3,7385,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7385,1,4,0)
 ;;=4^V17.5
 ;;^UTILITY(U,$J,358.3,7385,1,5,0)
 ;;=5^Family h/o Asthma
 ;;^UTILITY(U,$J,358.3,7385,2)
 ;;=^295307
 ;;^UTILITY(U,$J,358.3,7386,0)
 ;;=V17.7^^55^580^3
 ;;^UTILITY(U,$J,358.3,7386,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7386,1,4,0)
 ;;=4^V17.7
 ;;^UTILITY(U,$J,358.3,7386,1,5,0)
 ;;=5^Family h/o Arthritis
 ;;^UTILITY(U,$J,358.3,7386,2)
 ;;=^295309
 ;;^UTILITY(U,$J,358.3,7387,0)
 ;;=V19.0^^55^580^5
 ;;^UTILITY(U,$J,358.3,7387,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7387,1,4,0)
 ;;=4^V19.0
 ;;^UTILITY(U,$J,358.3,7387,1,5,0)
 ;;=5^Family h/o Blindness
 ;;^UTILITY(U,$J,358.3,7387,2)
 ;;=^295320
 ;;^UTILITY(U,$J,358.3,7388,0)
 ;;=V16.3^^55^580^6
 ;;^UTILITY(U,$J,358.3,7388,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7388,1,4,0)
 ;;=4^V16.3
 ;;^UTILITY(U,$J,358.3,7388,1,5,0)
 ;;=5^Family h/o Cancer of Breast
 ;;^UTILITY(U,$J,358.3,7388,2)
 ;;=^295295
 ;;^UTILITY(U,$J,358.3,7389,0)
 ;;=V16.41^^55^580^9
 ;;^UTILITY(U,$J,358.3,7389,1,0)
 ;;=^358.31IA^5^2
